Literature DB >> 21226667

Pentraxins and atherosclerosis: the role of PTX3.

Cecilia Garlanda1, Barbara Bottazzi, Federica Moalli, Livija Deban, Fabiola Molla, Roberto Latini, Alberto Mantovani.   

Abstract

Pentraxins are a family of evolutionarily conserved multifunctional pattern-recognition proteins characterized by a cyclic multimeric structure. Based on the primary structure of the subunit, the pentraxins are divided into two groups: short pentraxins and long pentraxins. C-reactive protein (CRP) and serum amyloid P-component (SAP) are the two short pentraxins. The prototype protein of the long pentraxin group is pentraxin 3 (PTX3). CRP and SAP are produced primarily in the liver in response to IL-6, while PTX3 is produced by a variety of tissues and cells and in particular by innate immunity cells in response to proinflammatory signals and Toll-like receptor (TLR) engagement. PTX3 interacts with several ligands, including growth factors, extracellular matrix components and selected pathogens, playing a role in complement activation and facilitating pathogen recognition by phagocytes, acting as a predecessor of antibodies. In addition, PTX3 is essential in female fertility by acting as a nodal point for the assembly of the cumulus oophorus hyaluronan-rich extracellular matrix. Here we will concisely review the general properties of PTX3 in the context of the pentraxin superfamily and discuss recent data suggesting that PTX3 plays a cardiovascular protective effect. PTX3 may represent a new marker in vascular pathology which correlates with the risk of developing vascular events.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21226667     DOI: 10.2174/138161211795049750

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  23 in total

1.  Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study.

Authors:  Ruth Dubin; Yongmei Li; Joachim H Ix; Michael G Shlipak; Mary Whooley; Carmen A Peralta
Journal:  Am Heart J       Date:  2012-02       Impact factor: 4.749

2.  High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients.

Authors:  Matti Vänskä; Irma Koivula; Sari Hämäläinen; Kari Pulkki; Tapio Nousiainen; Esa Jantunen; Auni Juutilainen
Journal:  Haematologica       Date:  2011-09       Impact factor: 9.941

3.  Absence of inflammatory conditions in human varicose saphenous veins.

Authors:  Ingrid Gomez; Chabha Benyahia; Julien Le Dall; Christine Payré; Liliane Louedec; Guy Leséche; Gérard Lambeau; Dan Longrois; Xavier Norel
Journal:  Inflamm Res       Date:  2012-12-13       Impact factor: 4.575

Review 4.  Childhood obesity-related endothelial dysfunction: an update on pathophysiological mechanisms and diagnostic advancements.

Authors:  Luc Bruyndonckx; Vicky Y Hoymans; Katrien Lemmens; José Ramet; Christiaan J Vrints
Journal:  Pediatr Res       Date:  2016-02-11       Impact factor: 3.756

5.  PTX3 controls activation of matrix metalloproteinase 1 and apoptosis in conjunctivochalasis fibroblasts.

Authors:  Ping Guo; Su-Zhen Zhang; Hua He; Ying-Ting Zhu; Scheffer C G Tseng
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-08       Impact factor: 4.799

6.  TREM-1 and pentraxin-3 plasma levels and their association with obstructive sleep apnea, obesity, and endothelial function in children.

Authors:  Jinkwan Kim; David Gozal; Rakesh Bhattacharjee; Leila Kheirandish-Gozal
Journal:  Sleep       Date:  2013-06-01       Impact factor: 5.849

7.  A RTK-based functional RNAi screen reveals determinants of PTX-3 expression.

Authors:  Hua Liu; Xin-Kai Qu; Fang Yuan; Min Zhang; Wei-Yi Fang
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

8.  Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.

Authors:  Anna Witasp; Mikael Rydén; Juan Jesús Carrero; Abdul Rashid Qureshi; Louise Nordfors; Erik Näslund; Folke Hammarqvist; Samsul Arefin; Karolina Kublickiene; Peter Stenvinkel
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

9.  Associations between pentraxin 3 and severity of coronary artery disease.

Authors:  Hua Liu; Shaofeng Guan; Weiyi Fang; Fang Yuan; Min Zhang; Xinkai Qu
Journal:  BMJ Open       Date:  2015-04-08       Impact factor: 2.692

10.  Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study.

Authors:  Raija Uusitalo-Seppälä; Reetta Huttunen; Janne Aittoniemi; Pertti Koskinen; Aila Leino; Tero Vahlberg; Esa M Rintala
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.